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The hypoxia-inducible factor (HIF) is a key regulator of the transcriptional response to hypoxia. While the
mechanism underpinning HIF activation is well understood, little is known about its resolution. Both the
protein and the mRNA levels of HIF-1 (but not HIF-2) were decreased in intestinal epithelial cells exposed
to prolonged hypoxia. Coincident with this, microRNA (miRNA) array analysis revealed multiple hypoxia-
inducible miRNAs. Among these was miRNA-155 (miR-155), which is predicted to target HIF-1 mRNA. We
confirmed the hypoxic upregulation of miR-155 in cultured cells and intestinal tissue from mice exposed to
hypoxia. Furthermore, a role for HIF-1 in the induction of miR-155 in hypoxia was suggested by the
identification of hypoxia response elements in the miR-155 promoter and confirmed experimentally. Applica-
tion of miR-155 decreased the HIF-1 mRNA, protein, and transcriptional activity in hypoxia, and neutral-
ization of endogenous miR-155 reversed the resolution of HIF-1 stabilization and activity. Based on these
data and a mathematical model of HIF-1 suppression by miR-155, we propose that miR-155 induction
contributes to an isoform-specific negative-feedback loop for the resolution of HIF-1 activity in cells exposed
to prolonged hypoxia, leading to oscillatory behavior of HIF-1-dependent transcription.
Tissue hypoxia is a common feature in a range of physiologic
and pathophysiologic states, including exercise, development,
cancer, and chronic inflammation. The hypoxia-inducible fac-
tor (HIF) is a ubiquitous hypoxia-responsive transcription fac-
tor that regulates the expression of a range of genes that
promote adaptation to hypoxia (32, 57). The mechanism by
which HIF is stabilized in hypoxia is well understood and is
due to reduced activity of a family of oxygen-dependent HIF-
hydroxylases that target HIF subunits for degradation and
block transactivation in normoxia (5). Several studies (includ-
ing the present one) have shown that the upregulation of
HIF-1 that occurs in response to hypoxia is transient and
involves a resolution phase even while the cells are maintained
in hypoxia (23, 26, 59). However, the mechanism(s) underpin-
ning the resolution of HIF-1 during prolonged hypoxia re-
mains incompletely understood. Negative-feedback mechanisms
involving HIF-dependent upregulation of PHD2 and PHD3 have
been identified (5, 26, 47, 59). In the present study, we aimed to
expand our understanding of how the HIF response is resolved in
prolonged hypoxia by investigating a possible role for hypoxia-
induced microRNAs (miRNAs).
miRNAs are endogenous small RNA molecules of approx-
imately 22 nucleotides that regulate gene expression by desta-
bilizing mRNA or repressing translation (4, 25). Approxi-
mately one-third of all genes in mammals have been predicted
to be regulated by miRNAs (43, 71), and the development of
our understanding of the role of miRNAs in various species is
ongoing (39, 40). Individual miRNAs may target hundreds of
distinct mRNAs. miRNA target prediction algorithms, includ-
ing miRanda, TargetScan, and PicTar, can be used to predict
theoretical targets for specific miRNAs; however, biological
confirmation of these targets is required to confirm bona fide
targets (24, 36, 44). The regulation of protein expression by
miRNAs impacts upon all physiological processes examined
thus far, including hematopoiesis, development, cell prolifera-
tion, apoptosis, immunity, and metabolism (3, 69). Further-
more, altered expression of specific miRNAs is often associ-
ated with the interrelated pathologies of chronic inflammation
and tumor development (18, 31, 46, 72). Importantly, such
pathophysiologic events often feature microenvironmental
hypoxia due to decreased tissue perfusion and/or increased
oxygen consumption (14).
Recent work has demonstrated altered global miRNA ex-
pression in response to hypoxia (22, 38). While a limited num-
ber of individual miRNAs (e.g., miRNA-210 [miR-210]) are
regulated by hypoxia in most models tested, many other
miRNAs appear to be regulated by hypoxia in a cell type/
tissue-specific manner (29, 37). The functions of hypoxia-in-
duced miRNAs such as miR-210 include regulation of apop-
tosis, proliferation, cell cycle, DNA repair, cell migration, and
mitochondrial function (7, 13, 15, 17, 19, 29, 34, 37, 52). How-
ever, our understanding of the function of alternative hypoxia-
induced miRNAs at the cellular level remains limited. In the
present study, we provide evidence that HIF-1 is a direct
target of miR-155, a hypoxia-inducible miRNA, in intestinal
epithelial cells. HIF-1-dependent signaling is reduced by
miR-155. Furthermore, HIF-1 is the transcription factor pri-
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marily responsible for miR-155 induction in hypoxia. We hy-
pothesize, based on these data and a mathematical model of
miR-155 regulation of HIF-1 mRNA, that miR-155 is a com-
ponent of the network of negative-feedback loops responsible
for the resolution of HIF-1-dependent transcription in pro-
longed hypoxia.
MATERIALS AND METHODS
Cell culture and hypoxia. Caco-2 cells and murine embryonic fibroblasts
(MEFs) were maintained in Dulbecco modified Eagle medium containing 4.5 g
of glucose/liter, 10% fetal calf serum (FCS), 2 mM L-glutamine, and 10 U/ml of
penicillin-streptomycin. HeLa and HepG2 cells were maintained in minimum
essential medium containing 10% FCS, 2 mM L-glutamine, nonessential amino
acids, and 10 U of penicillin-streptomycin/ml. Medium for stable transfected
HepG2 cells additionally contained 2 g of puromycin dihydrochloride/ml.
Caco-2, MEF, HepG2, and HeLa cells were placed in a hypoxia chamber (Coy
Laboratories, Grass Lake, MI) with a normobaric atmosphere of humidified,
ambient hypoxia of 1%O2, 5%CO2, and a balance of N2. Temperature was
maintained at 37°C, and instantaneous hypoxia was achieved by feeding cells in
the hypoxia chamber immediately with preconditioned medium.
Microarray analysis. Caco-2 cells were exposed to 1%O2 for 0, 8, 24, or 48 h.
Total RNA was purified using an miRNeasy minikit (Qiagen) according to the
manufacturer’s protocol. The integrity of total RNA was analyzed by agarose gel
electrophoresis and by RNA 6000 Nano assay using a 2100 Bioanalyzer (Agilent
Technologies). miRNA array analysis was carried out on 20 g of each sample
(LC Sciences). The Paraflo microfluidics chip allowed the analysis of 856
known human miRNAs in each sample using RNA labeled with cyanin 3 (Cy3)
and Cy5 dyes prior to hybridization. Significant changes in miRNA expression
were identified using an analysis of variance (ANOVA) t test (P  0.01).
Immunoblot analysis. Cells were washed with phosphate-buffered saline and
lysed on ice in whole-cell lysis buffer (150 mM sodium chloride, 25 mM Tris [pH
8.0], 1 mM EDTA, 1% [vol/vol] NP-40) containing protease inhibitor cocktail
(Sigma, St. Louis, MO). Cytosolic and nuclear extracts were prepared as de-
scribed previously (16). After normalization (DC protein assay; Bio-Rad), sam-
ples (15 g/lane) were separated by SDS-PAGE and transferred to nitrocellu-
lose. For immunoblotting, blots were incubated with anti-human HIF-1 (BD
Biosciences), anti-HIF-2 (Novus Biosciences), TATA box binding protein
(TBP; Abcam), -tubulin (Cedarlane), and anti--actin (Sigma) for 8 h at 4°C on
FIG. 1. Differential expression of HIF subunits in hypoxia and potential role for hypoxia-induced miRNAs. (A) Caco-2 colonic epithelial cells
exposed to 0 to 48 h of hypoxia (1% O2) demonstrate a transient increase in cytosolic and nuclear HIF-1 and a sustained increase in HIF-2
protein levels. -Tubulin and TATA-box binding protein (TBP) were used as loading controls. (B) Real-time PCR analysis normalized to the
corresponding normoxic control was used to determine HIF-1 and HIF-2  mRNA levels in Caco-2 cells exposed to hypoxia. (C) miRNA array
analysis identified a cohort of hypoxia-induced miRNAs in Caco-2 cells. Those miRNAs previously identified as hypoxia-inducible are outlined in
bold. The last three miRNAs are included as sample controls that were not induced in hypoxia. (D) HIF-1 is a predicted target of miR-155.
Watson-Crick base pairing is indicated by solid lines, while non-Watson-Crick base pairing is indicated by dashed lines. In all cases, n  3 to 4
independent experiments. The data are shown as representative blots or means  the standard errors of the mean (SEM) (*, P  0.05; nsd, no
significant difference).
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a rocking platform. Blots were then washed and species matched secondary
horseradish peroxidase-conjugated antibodies were added for 1 h. Bands were
detected by using ECL reagent (Santa Cruz Biotechnology).
Transient transfections and luciferase reporter assay. Caco-2 cells were trans-
fected with 20 to 80 nM mature miRNAs, anti-miRs (Ambion), HIF-1 siRNA (30
nM), HIF-2 siRNA (100 nM), or RelA/p65 siRNA (40 nM) (ON-TARGETplus
SMARTpool; Dharmacon) using Lipofectamine 2000 (Invitrogen) according to the
manufacturer’s protocol. An anti-miR negative control and nontarget small inter-
fering (siRNA) were used as controls where appropriate. At 24 h after transfection,
the medium was replaced, and hypoxia exposure was started 48 h after transfection.
For luciferase experiments 24 h after siRNA/miRNA transfection, the cells were
transfected with either an HRE-luciferase reporter construct (Promega) or pmiR-
report construct (Applied Biosystems) (cloning was performed according the man-
ufacturer’s protocol) using FuGene 6 transfection reagent (Roche Applied Science).
A pSV--Gal vector (Promega) was cotransfected for normalization. For transient
overexpression of PHD2 or PHD3, 0.5 g of a V5-tag construct was transfected into
Caco-2 cells using FuGene 6, and pcDNA 3.1 empty vector was used as negative
control. At 24 h after transfection, the medium was replaced, and the cells were
exposed to hypoxia for the indicated experimental conditions. The cells were lysed in
1 reporter lysis buffer (Promega). Luciferin/ATP substrate (Promega) was added
to cell lysate, and the luciferase activity was detected in a luminometer (Berthold
Technologies). All samples were run in duplicate and normalized to cotransfected
-galactosidase (-Gal). A secreted luciferase assay was carried out according to the
manufacturer’s protocol (Biolux Gaussia luciferase flex assay kit; NEB) and normal-
ized to the cell number.
miRNA real-time PCR. Total RNA was purified from cells or tissue by using
a miRNeasy minikit (Qiagen) according to the manufacturer’s protocol. The
RNA concentration was measured by using a NanoDrop apparatus (NanoDrop
Technology, Inc.) and normalized, and the RNA integrity was determined by
agarose gel electrophoresis. Reverse transcription was carried out using a
TaqMan MicroRNA reverse transcription kit (Applied Biosystems) according
to the manufacturer’s protocol. Hsa-miR-155, mmu-miR-155, pri-miR-155,
and hsa-miR-215 were detected using TaqMan MicroRNA assays. Real-time
quantification of cDNA was carried out on an ABI Prism 7900HT sequence
detection system (Applied Biosystems) and normalized to 18S rRNA.
mRNA real-time PCR. Total RNA was purified using the TRIzol (Invitrogen)
method, and reverse transcription was carried out using Superscript II (Invitro-
gen). Real time quantification of cDNA was carried out on the ABI Prism
7900HT sequence detection system and normalized to 18S rRNA. For HIF-1,
HIF-2, and PHD-2, the following primers were used: HIF-1 fwd 5-ACCAT
GCCCCAGATTCAGG-3; HIF-1 rev, 5-AGTGCTTCCATCGGAAGGAC
T-3; HIF-2 fwd, 5-CTACGCCACCCAGTACCAGG-3; HIF-2 rev, 5-GA
CACCTTGTGGGCTGACG-3; PHD-2 fwd, 5-ACATAACCCGTTCCATTG
CC-3; and PHD-2 rev, 5-ATCAATGGCCGGACGAAAG-3.
Animal studies. C57BL/6 mice were exposed to 10% O2 for the indicated
times, and the tissue was snap-frozen and stored at 	80°C. All experiments were
carried out with prior ethical approval from the University College Dublin
Animal Research Ethics Committee.
Bioinformatic analysis. The miRanda algorithm (www.microRNA.org) was
used to identify predicted potential miRNA targets. For promoter analysis stud-
ies, MatInspector software (Genomatix) was used.
Mathematical model of the HIF pathway. We developed a computational
model, based on differential equations, to study the role of miR-155 and PHD2/3
in downregulating HIF-1 mRNA and, consequently, the HIF-1 protein levels.
Numerical simulations and parameter estimation have been performed using
Matlab.
Statistical analysis. All data are presented as mean  the SEM of the indi-
cated n independent experiments. Statistical significance was assessed using an
FIG. 2. Transcriptional upregulation of miR-155 in response to hypoxia. (A) Real-time PCR analysis demonstrates mature miR-155 expression
in Caco-2 cells exposed to hypoxia. (B and C) Mir-155 expression levels from colon and liver tissue, respectively, harvested from mice exposed to
10% atmospheric O2 for the indicated periods. (D and E) Caco-2 and HeLa cells were treated with (or without) actinomycin D and exposed to
48 h of hypoxia. Real-time PCR analysis was used to measure primary transcript pri-miR-155 expression in response to hypoxia. All data are shown
as the fold over basal miR-155 or pri-miR-155 expression, with 18S rRNA being used as an endogenous control. n  3 independent experiments
for in vitro experiments. n  6 independent mice were used for in vivo measurements. Values are presented as means  the SEM (*, P  0.05).
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ANOVA t test for the array data and the unpaired two-tailed Student t test for
all other experiments. The significance is indicated in the figures (, P 0.05; ,
P  0.01.
RESULTS
Transient activation of HIF-1 in hypoxia. Caco-2 cells ex-
posed to hypoxia (0 to 48 h) demonstrated differential HIF
subunit expression patterns. Although both nuclear and cyto-
plasmic HIF-1 protein levels were transiently increased,
HIF-2 protein levels were increased in a sustained manner
(Fig. 1A). The HIF-1mRNA levels were also reduced at later
time points of hypoxic exposure, whereas the HIF-2 mRNA
levels were unchanged (Fig. 1B). These data led us to investi-
gate the presence of a specific resolving mechanism for HIF-1
in prolonged hypoxia mediated through decreased expression
of HIF-1 mRNA.
Hypoxia induces the expression of miR-155. miRNA array
analysis of Caco-2 cells exposed to hypoxia revealed ca. 12% of
miRNAs studied to demonstrate significant and consistent al-
tered expression levels in response to hypoxia. In Fig. 1C, we
list the cohort of the most significantly upregulated miRNAs,
which included the previously characterized hypoxia-depen-
dent miRNA, miR-210 (38). miRNAs previously reported to
be hypoxia inducible are indicated in Fig. 1C in boldface.
Three control miRNAs with unchanged expression levels in
hypoxia are also included (miR-222, miR-27b, and miR-25).
We next used the bioinformatic algorithms miRanda and
PicTar (6, 12, 36) to identify the predicted targets of the
hypoxia-upregulated miRNAs. HIF-1 was identified as a po-
tential target for just one of the hypoxia-induced miRNAs,
miR-155 (Fig. 1D). The alignment scores represent a weighted
summary of matches and mismatches for individual base pairs
FIG. 3. HIF-1-dependent miR-155 expression in hypoxia. (A) Bioinformatic analysis using the Genomatix software tool MatInspector reveals
the presence of three HRE consensus motifs and two NRE consensus motifs in the promoter of the miR-155 gene. (B) Effective siRNA-dependent
knockdown of HIF-1, HIF-2, and p65 was confirmed by immunoblot analysis. (C) Caco-2 cells were transfected with HIF-1, HIF-2, or
p65-siRNA prior to hypoxic exposure (48 h), and mature miR-155 expression was analyzed by real-time PCR. (D) Protein levels of HIF subunits
in HIF-1 or HIF-2 knockdown HepG2 cells were analyzed by immunoblotting. (E) HepG2 cells stably expressing shRNA directed against
HIF-1 or HIF-2 were exposed to hypoxia, and pri-miR-155 expression was measured by using real-time PCR. n four independent experiments
throughout. Values are presented as means  the SEM (*, P  0.05; **, P  0.01).
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and gaps. miR-155 was not predicted to target HIF-2 mRNA
since it does not contain a miR-155 binding site in its 3 un-
translated region (3UTR). miR-215, which was increased in
hypoxia to approximately the same degree as miR-155 but was
not predicted to target HIF-1 mRNA, was selected for use as
a negative control miRNA for subsequent experiments. Real-
time PCR was used to validate the array data and confirm the
upregulation of mature miR-155 in Caco-2 cells (Fig. 2A).
Hypoxia also induced miR-155 in HeLa cells, another trans-
formed epithelial cell line (data not shown), but not in
primary MEFs (data not shown). In order to determine
whether hypoxic induction of miR-155 occurs in vivo, we
determined mature miR-155 levels in tissues from mice ex-
posed to atmospheric hypoxia. Hypoxia upregulated miR-
155 expression levels in the colon (Fig. 2B) and liver (Fig.
2C) but not in the small intestine (data not shown), indicat-
ing a tissue-specific response. To determine whether the miR-155
upregulation in hypoxia is due to increased transcription, the
expression of the primary transcript pri-miR-155 was measured in
Caco-2 and HeLa cells. The pri-miR-155 transcript was induced
in response to hypoxia, and this effect was diminished when cells
were treated with the inhibitor of transcription actinomycin D
(Fig. 2D and E). Together, these results implicate miR-155 to be
a cell type-specific and tissue-specific hypoxia-induced miRNA
and that the induction of miR-155 occurs at least in part at the
level of transcriptional upregulation.
HIF-1 contributes to hypoxic miR-155 induction. We next
investigated the potential molecular regulators of miRNA-155
expression in hypoxia. Using bioinformatic analysis (MatInspec-
tor), three HIF response elements (HREs) and two NF-
B con-
sensus motifs (NREs) were identified in the 600-bp promoter
region of miR-155 that is 11 kbp upstream from the actual
miR-155 gene BIC on chromosome 21 (Fig. 3A). Protein knock-
down with all siRNA treatments was confirmed by immunoblot-
ting (Fig. 3B). Caco-2 cells transfected with siRNA against
HIF-1 but not HIF-2 or the RelA/p65 subunit of NF-
B dem-
onstrate significantly decreased induction of miR-155 expression
in response to hypoxia compared to cells pretreated with nontar-
get siRNA (Fig. 3C). The incomplete knockdown of HIF-1 with
siRNA likely explains the residual miR-155 induction in hypoxia
seen in Fig. 3C. In the hepatocellular carcinoma cell line HepG2
stably expressing short hairpin RNA (shRNA) targeted against
HIF-1 or HIF-2, HIF-1 dependence for hypoxic pri-miR-155
induction was also observed (Fig. 3D and E). These data impli-
cate HIF-1 as the transcription factor primarily responsible for
the hypoxic induction of miR-155.
miR-155 reduces HIF signaling. We next investigated whether
HIF-1 was a bona fide functional target for miR-155. Using a
HRE-luciferase reporter assay, we found that exogenously ap-
plied mature miR-155 reduced hypoxia-induced HIF activity in a
manner that could be reversed by cotreatment with neutralizing
anti-miR-155 (Fig. 4A). In contrast, miR-215, also induced in
Caco-2 cells exposed to hypoxia, was without effect on basal or
hypoxia-induced HIF activity (data not shown). Transfection with
exogenous miRNA-155 induced a mild but significant reduction
in HIF-1mRNA levels in normoxic cells (Fig. 4B). Transfection
of miR-155 also resulted in an inhibition of hypoxia-induced
HIF-1 (but not HIF-2) protein expression (Fig. 4C). Further-
more, real-time PCR analysis of hypoxia-induced expression of
prolyl hydroxylase 2 (PHD2), a downstream target gene of HIF-
1, also showed a significant reduction in cells treated with miR-
155 (Fig. 4D). Using a miRNA expression reporter vector system
(pmiR-report) with wild-type and mutant versions of the pre-
dicted miR-155 binding site from the HIF-1 3UTR inserted
into a firefly luciferase construct showed HIF-1 to be a direct
target of miR-155 (Fig. 5A and B). Furthermore, increasing
concentrations of miR-155 reduce HIF-1 mRNA and protein
specifically in a dose-response manner (Fig. 5C and D). Taken
together, these data indicate that miR-155 specifically and se-
lectively targets HIF-1 over HIF-2 through direct targeting
of HIF-1 (but not HIF-2) mRNA.
Inhibition of endogenous miR-155 induces sustained HIF-1
activation in hypoxia. To investigate whether inhibition of miR-
155 alters the transient nature of HIF-1 activation in hypoxia,
FIG. 4. miR-155 reduces HIF signaling. (A) Caco-2 cells cotrans-
fected with HRE-luciferase and either control siRNA (si-NT), HIF-1
siRNA (si-HIF-1), or miR-155 with or without anti-miR-155 and
exposed to 6 h of 1% O2. A luciferase assay was carried out, and the
values were normalized to cotransfected -Gal. (B) Real-time PCR
analysis of HIF-1 mRNA levels in Caco-2 cells in normoxia following
transfection with miR-155. HIF-1 siRNA was used as positive con-
trol. (C) Immunoblot analysis reveals HIF-1 and HIF-2 protein
levels after transfection with miR-155 for 48 h prior to hypoxic expo-
sure for 8 h. (D) Caco-2 cells were transfected with miR-155, and
hypoxia-induced PHD2 mRNA expression was determined by real-
time PCR analysis. In all cases n  3 to 4 independent experiments.
The data are shown as representative blots or as means  the SEM (*,
P  0.05; **, P  0.01).
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cells were treated with anti-miR-155 prior to hypoxic exposure.
As described earlier, Caco-2 cells exposed to hypoxia demon-
strated a transient increase in whole-cell HIF-1 protein and a
sustained increase of HIF-2 protein levels (Fig. 6) in both
Caco-2 and HeLa cells. However, cells pretreated with anti-miR-
155 demonstrated sustained increase in HIF-1 protein levels
compared to the transient HIF-1 activation in control anti-miR
treatment (Fig. 6). Total HIF-2 protein levels over time in hyp-
oxia were unchanged between all treatments (Fig. 6). These data
indicate a role for hypoxia-induced miR-155 in the resolution of
hypoxia-induced HIF-1 (but not HIF-2) activation in pro-
longed periods of hypoxia.
Mathematical model of HIF-1 regulation by miR-155 and
PHD2/3 negative-feedback loops. A predictive computational
model (based on differential equations) was developed to study
the relative roles of miR-155 and PHD2/3 in downregulating
HIF-1 mRNA and, consequently, reducing the HIF-1 pro-
tein level. In order for this model to accurately predict HIF-1
activity in prolonged hypoxia, it was necessary to include a
direct or indirect negative autoregulation of HIF-1 mRNA
when the HIF-1 protein increases above a threshold value.
Although this type of regulation has not yet been reported for
HIF in the literature, such negative autoregulation has been
proposed to be a general control motif in gene transcription
networks and has a compensatory role allowing for a faster
response to changes in transcription factor activity (1). Using
this model, in Fig. 7A the difference from the x axis reflects
deviation from the normal temporal HIF-1 activation profile.
Removal of the PHD-dependent feedback loop from the
model leads to predictive deviation in the early but not in the
late regulation of HIF-1 response to hypoxia (red). In con-
trast, removal of the miR-155-dependent negative-feedback
FIG. 5. HIF-1 is a direct target of miR-155. (A) Wild-type (WT) and mutant (MT) versions of the predicted miR-155 binding site in the
3UTR of HIF-1 mRNA were cloned into a luciferase vector. (B) Caco-2 and HeLa cells were transfected with miR-155 (155) or miR-control
(ctl) 24 h prior to transfection with the reporter luciferase construct. After 24 h, a luciferase assay was carried out and normalized to the
cotransfected -Gal. (C and D) HeLa and Caco-2 cells were transfected with increasing doses of either miR-155 or miR-control (miR-ctl), and
the HIF protein or mRNA levels were measured. For the HIF-1 mRNA statistical data, comparisons were made to the corresponding
concentration of the control RNA. n  3 to 4 independent experiments throughout. The data shown are representative blots or means  the SEM
(*, P  0.05; **, P  0.01).
4092 BRUNING ET AL. MOL. CELL. BIOL.
loop leads to late but not early deviation from the normal
HIF-1 response to hypoxia (green). Removal of both feed-
back loops leads to both early and late deviation (blue). In sum-
mary, using this predictive model, we estimate that PHD2/3 and
miR-155 feedback loops play temporally distinct roles in the reg-
ulation of HIF-1 activity in prolonged hypoxia (Fig. 7B). Inter-
estingly, on longer timescales (50 h) the computational model
predicts that the establishment of periodic oscillations in HIF-1
protein concentration is a consequence of the negative-feedback
loop through miR-155. Such oscillations have been proposed to
be important in selective target gene activation for other tran-
scription factors such as NF-
B (2, 51, 60, 63). In order to test the
prediction of oscillatory behavior of HIF, we generated a vector
containing a secreted form of luciferase (derived from Gaussia
princeps) under the control of an HRE promoter. This construct
allows high-resolution, temporal measurement of HIF transcrip-
tional activity in response to hypoxia. In a time course experiment,
we presented the first evidence that HIF activity is increasing in
an oscillatory and not sustained fashion in response to prolonged
hypoxia (Fig. 7C).
Multiple negative-feedback loops in the HIF pathway. A
number of previous studies have demonstrated a role for in-
creased expression/activity of PHD2 and PHD3 in prolonged
hypoxia in the resolution of HIF signaling. In agreement with
this, we found that the overexpression of either PHD2 or
PHD3 was sufficient to decrease hypoxia-induced HIF activity
(data not shown). However, since PHDs suppress the level of
the HIF-1 protein stability (and do not suppress HIF-1
mRNA expression), this pathway does not fully account for the
negative feedback we observed in the present study. In sum-
mary, miR-155, an miRNA induced in hypoxia in a HIF-1-
dependent manner, represents a component of the negative-
feedback loop network (Fig. 7B) responsible for the resolution
of selectively HIF-1 activation in prolonged hypoxia, and this
negative feedback is effective at the level of the inhibition of
translation.
DISCUSSION
HIF-1 is a key transcriptional regulator of the cellular
response to hypoxia in all metazoans (57). The stabilization
and transactivation of HIF-1 during hypoxia is primarily reg-
ulated by altered HIF-1 hydroxylation (32). Less is known
about the processes involved in the resolution of HIF-1 ac-
tivity. A number of studies have demonstrated that the reso-
lution of HIF-1 observed in prolonged hypoxia is due to
increased activity and expression of PHD2 and PHD3 (23, 26,
47, 59). Because PHD2 and PHD3 are themselves HIF-depen-
FIG. 6. Inhibition of miR-155 sustains HIF-1 activation in hypoxia. (A) Caco-2 and HeLa cells were transfected with nonspecific anti-miR
control or anti-miR-155 oligonucleotides 24 h prior to hypoxic exposure over time (0 to 48 h). The HIF-1 and HIF-2 levels were analyzed in
whole-cell protein extracts by immunoblotting. (B) HIF/-actin ratios of densitometric analysis are shown from n  3 independent experiments
in each case.
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dent genes and retain some activity even under hypoxic con-
ditions, this represents an effective negative-feedback loop for
HIF signaling that prevents excessive activation of the HIF
pathway that could prove detrimental to cells and tissues. A
further negative-feedback loop for HIF signaling in hypoxia
that involves components of the E3 ubiquitin ligase has also
been proposed (62). In the present study, we have found that
intestinal epithelial cells exposed to prolonged hypoxia dem-
onstrate a transient and resolving HIF-1 (but not HIF-2)
response and that the resolution of this response is at least in
part due to decreased expression of HIF-1 mRNA. Because
this response is specific for HIF-1 and is associated with
decreased mRNA levels, it cannot be fully accounted for by
altered PHD2/3 expression or HIF-1 protein degradation.
Thus, we hypothesized the existence of a further negative-
feedback loop in the HIF pathway involving decreased trans-
lation of the HIF-1 gene.
miRNAs are key regulators of gene expression that act at the
posttranscriptional level (20, 70). Multiple studies have used mi-
croarray analysis to investigate a hypoxia-inducible microRNA
signature in various model systems. Although it is clear that hyp-
oxia regulates the expression of miRNAs, strong evidence for
biological targets and functions remain to be confirmed. To date,
miR-210 is the miRNA most convincingly shown to be hypoxia
induced in a manner independent of tissue or cell line used (37,
38). Notably, while HIF can increase the expression of miRNAs,
it can also be an miRNA target. For example, various reports
have shown that HIF is a target of the miR-17-92 cluster, miR-
199a, miR-519c, and miR-20b (9, 11, 41, 54, 58, 61). The consti-
tutively expressed HIF-1 subunit has been shown to be a target
of p53-induced miR-107 with repressive effects on tumor angio-
genesis (72). A very recent study investigated an indirect
positive-feedback loop for HIF-1 in hypoxia through miR-
210 by targeting glycerol-3-phosphate dehydrogenase 1-like
(GPD1L), a negative regulator of PHDs (33). In the present
study, we have identified miR-155 as a hypoxia-inducible
HIF-1-dependent miRNA in colon cancer cells that specif-
ically targets HIF-1 mRNA and thus forms part of the
network of HIF-1 negative-feedback loops responsible for
the resolution of HIF-dependent transcription in hypoxia.
Interestingly, miR-155 has been shown to be an important
regulator of gene translation in multiple physiological and
pathophysiological states, including hematopoiesis, inflam-
mation (49, 50), and cancer (42). In one study miR-155 was
shown to target HIF-1 in a monocyte cell line (50). We
found miR-155 to be induced by hypoxia in a cell type and
tissue-specific manner, which indicates a possible specific
role in intestinal epithelial cells. In the study of Lei et al.
(41) the expression of miR-155 was unchanged in hypoxia.
That study used one time point and did not define the
degree of hypoxia. In the present study miR-155 expression
was upregulated in prolonged hypoxia in multiple cell lines
and tissues, a finding that is in agreement with previous
studies (28, 48; reviewed in reference 37). We show here for
the first time that inhibition of HIF-1 expression through miR-
155 results in a reduction of HIF-1-dependent signaling. The
HIF-2 isoform is not affected by miR-155. miRNA-155 has been
predicted to play a role in tumor development. For example,
miR-155 expression contributes to tumor size in a breast cancer
model and it has thus been termed an “OncomiR” (30). In colo-
rectal cancer, miR-155 was shown to target key proteins of DNA
damage repair (MLH1, MSH2, and MSH6) and therefore induce
a mutative phenotype in cancer tissues (67). These results dem-
onstrate that a single miRNA can be sufficient to impact upon
disease progression in cancer. The overexpression of miR-155 has
been reported in acute myeloid leukemia patients (49), and miR-
155 was shown to regulate the survival and proliferation in mel-
anoma cells (42). Overall, in recent studies a high expression of
miR-155 in tumors is correlated with aggressive tumor growth in
different systems. By targeting the tumor-suppressor SMAD5,
miR-155 was demonstrated to contribute to the aggressiveness of
lymphomagenesis (53). Two groups showed independently the
pro-proliferative effect of miR-155 in breast cancer. Suppressor of
cytokine signaling 1 (SOCS1) was identified to be a target of
miR-155, which led to an induction of proliferation in breast
cancer cells (30). In a similar model miR-155 was shown to pro-
mote survival, tumor growth, and chemoresistance by targeting
FIG. 7. PHD2/3 and miR-155 negative-feedback loops are part of
the regulatory network of HIF-1 in prolonged hypoxia. A computa-
tional model based on experimental data was generated to estimate the
relative contributions of miR-155 and PHD2/3 in determining tempo-
ral HIF-1 activity during prolonged periods of hypoxia. (A) Temporal
deviation from normal (transient) HIF-1 activity predicted by re-
moval of the PHD2/3 feedback loop, the miR-155 feedback loop, or
both feedback loops from the model are shown in red, green, and blue,
respectively. (B) Schematic representation of the proposed network of
known and predicted negative-feedback loops in the HIF-1a pathway.
The “?” indicates currently unidentified direct or indirect negative-
feedback mechanism(s). (C) Caco-2 cells were transfected with a vec-
tor containing an HRE promoter controlling expression of a secreted
form of luciferase derived from Gaussia princeps and cultured under
normoxia (21% O2; red) or hypoxia (1% O2; black). The medium was
sampled every 3 h, and the HRE-luciferase activity assessed for each
time period and normalized to the cell number. Representative traces
are shown for HIF activity in arbitrary units (AU).
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FOXO3a (35). Taken together, the wide variety of miR-155
targets leads to a broad function of miR-155 in physiological
processes, such as hematopoiesis, and in pathophysiological pro-
cesses, such as tumor development. Although miR-155 was re-
ported to be upregulated under hypoxic conditions in a nasopha-
ryngeal cell line (28) and in VHL-deficient renal cancer cells (48),
the role of miR-155 in hypoxia remains unclear. Because hypoxia
is a key microenvironmental feature of a growing tumor, hypoxic
regulation of miR-155 may have profound implications for tumor
development. Clinical applications of miRNA technology include
potential use of miR-210 as a prognostic marker for breast, pan-
creatic and head and neck cancer (8, 21, 27). miRNA-155 may
also play an important role in regulating the immune response
(45, 50, 66) and has been proposed to be a critical player in the
cross talk between neoplastic development and inflammation
(65). Furthermore, in hematopoiesis, miR-155 is differentially
expressed in certain stages of blood cell differentiation, where it
plays an important role in B cell development (3). Multiple tar-
gets of miR-155 (Meis1, Ets-1, IKKε, IL-1, Pu.1, AID, and c-
MAF) have been identified which define its role both in hema-
topoiesis and in immune response (10, 45, 55, 56, 64, 68).
In summary, while HIF-1-dependent gene expression is a
key determinant of cell, tissue and organism adaptation to
hypoxia, excessive or inappropriate activation of this pathway
may result in pathological outcomes for the host. As a result,
negative-feedback loops that keep tight control of the HIF-1
pathway have evolved. In the present study, we propose that
hypoxia-induced miR-155 plays a role as a component of a
network of such negative-feedback loops which acts at the level
of control of HIF-1 mRNA translation. Such negative-feed-
back loops are likely crucial to ultimately determining the
temporal nature of the cellular transcriptional response to
hypoxia.
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